2-aminobenzimidazole has been researched along with Leishmaniasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Caljon, G; Campbell, S; Chelucci, RC; Dias, LC; Ferreira, LLG; Ferreira, RAA; Galuppo, MK; Junior, COR; Koovits, PJ; Kratz, JM; Maes, L; Martinez, PDG; Matheeussen, A; Michelan-Duarte, S; Mowbray, CE; Soares, BM; Uliana, SRB | 1 |
1 other study(ies) available for 2-aminobenzimidazole and Leishmaniasis
Article | Year |
---|---|
2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling.
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Disease Models, Animal; Drug Discovery; Female; Humans; Leishmania infantum; Leishmaniasis; Mice; Mice, Inbred BALB C; Microsomes, Liver | 2021 |